CHELSIE WORD: Open Payments
NPI 1952672057 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 24 payments from 10 companies in 2025. Trend: 2023 $1,503 · 2024 $1,096 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 3 | $82 |
| Regeneron Healthcare Solutions, Inc. | 4 | $82 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $78 |
| Genentech USA, Inc. | 2 | $60 |
| Incyte Corporation | 3 | $59 |
| Grifols USA, LLC | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| GENZYME CORPORATION | 2 | $48 |
| Pharming Healthcare, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: DUPIXENT, Hizentra, NEFFY, Xolair, OPZELURA, NUCALA, Prolastin-C Liquid, Xembify.
Industry payments across NM — which companies pay providers there.
